Lab-grown beating heart cells identify potential drug to prevent COVID-19-related heart damage
Cambridge scientists have grown beating heart cells in the lab and shown how they are vulnerable to SARS-CoV-2 infection. In a study published in Communications Biology, they used this system to show that an experimental peptide drug called DX600 can prevent the virus entering the heart cells. The heart is one the major organs damaged [...]Published August 05, 2021 at 01:49PM. Read full article at Stem Cells in the News Portal.
Comments
Post a Comment